The latest closing stock price for BioXcel Therapeutics as of November 20, 2024 is 0.59.
An investor who bought $1,000 worth of BioXcel Therapeutics stock at the IPO in 2018 would have $-947 today, roughly -1 times their original investment - a -34.22% compound annual growth rate over 7 years.
The all-time high BioXcel Therapeutics stock closing price was 64.63 on July 22, 2020.
The BioXcel Therapeutics 52-week high stock price is 4.17, which is 606.8% above the current share price.
The BioXcel Therapeutics 52-week low stock price is 0.50, which is 15.3% below the current share price.
The average BioXcel Therapeutics stock price for the last 52 weeks is 1.90.
An investor who bought $1,000 worth of BioXcel Therapeutics stock at the IPO in 2018 would have $-947 today, roughly -1 times their original investment - a -34.22% compound annual growth rate over 7 years.
The all-time high BioXcel Therapeutics stock closing price was 64.63 on July 22, 2020.
The BioXcel Therapeutics 52-week high stock price is 4.17, which is 606.8% above the current share price.
The BioXcel Therapeutics 52-week low stock price is 0.50, which is 15.3% below the current share price.
The average BioXcel Therapeutics stock price for the last 52 weeks is 1.90.